icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Boston MA
November 2019
Back grey_arrow_rt.gif
 
 
 
Italian real life experience of resistance guided retreatment in HCV infected patients who previously failed a NS5A inhibitor containing regimen
 
 
  AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
 
AASLD: The global prevalence of resistance-associated substitutions (RAS) in "unusual" HCV subtypes - (11/25/19)
 
AASLD: HCV Resistance Patterns in a Worldwide Network of Cohorts of GT-3a infected patients - (11/18/19)
 
V.C. Di Maio, M. Aragri, C. Masetti, S. Paolucci, B. Bruzzone, E. Degasperi, S. Barbaliscia, T. Pollicino, C. Minichini, V. Calvaruso, M. Rendina, V. Cento, E. Teti, V. Micheli, V. Ghisetti, E. Polilli, V. Pace Palitti, S. Landonio, I. Lenci, S. Francioso, L. Donnarumma, L.A. Nicolini, A. Bertoli, M. Starace, C. Pasquazzi, A.P. Callegaro, F. Morisco, G. Cenderello, S. Marenco, R. Gulminetti, S. Novati, A. Scuteri, P. Andreone, S. Galli, A. Ciancio, V. Sangiovanni, N. Cuomo, A. Raddi, G. Morsica, H. Hasson, V. Borghi, I. Maida, M. Brunetto, P. Colombatto, R. Cozzolongo, A. De Santis, M. Lichtner, S. Babudieri, E. Biliotti, G. Taliani, T. Santantonio, M. Di Stefano, C. Paternoster, R. Ganga, M. Puoti, G. Rizzardini, A. Pellicelli, E. Milano, C. Mastroianni, A. Licata, F. Di Lorenzo, A. Giorgini, L. Sighinolfi, C. Dentone, A. Lleo, B. Rossetti, I. Beretta, P. Lampertico, G. Parruti, N. Coppola, G. Raimondo, M. Zazzi, M. Andreoni, M. Angelico, C.F. Perno, A. Crax, F. Ceccherini-Silberstein# #on behalf of HCV Virology Italian Resistance Network (Vironet C)

0106201

0106202

0106203

0106204

0106205

0106206

0106207

0106208

0106209